methamphetamine has been researched along with ginsenosides in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, DH; Hong, YT; Jang, CG; Kim, HS; Oh, KW; Oh, S; Park, WK; Rheu, HM; Seong, YH | 1 |
| Li, X; Liu, W; Liu, YL; Song, M; Wang, JH; Wu, CF; Yang, JY | 1 |
| Choi, KH; Jhoo, WK; Kim, DS; Kim, HC; Lim, YK; Nabeshima, T; Oh, KW; Shin, EJ; Suh, HW | 1 |
| Eun, JS; Hong, JT; Jang, CG; Kim, HC; Lee, MK; Oh, KW; Shin, EJ | 1 |
| Jang, CG; Kim, HC; Ko, SK; Nabeshima, T; Nah, SY; Nguyen, TT; Park, DH; Shin, EJ; Shin, SW; Wie, MB; Yang, BW | 1 |
| Jang, CG; Jeong, JH; Kim, HC; Ko, SK; Nah, SY; Nam, Y; Nguyen, TT; Shin, EJ; Wie, MB | 1 |
| Fu, K; Lin, H; Miyamoto, Y; Nitta, A; Uno, K; Wu, C; Yang, J | 1 |
| Bing, G; Byun, JK; Dang, DK; Hong, JS; Jang, CG; Jeong, JH; Kim, DJ; Kim, HC; Ko, SK; Nah, SY; Shin, EJ; Tran, HQ | 1 |
| Dai, J; Hu, X; Li, J; Li, Z; Yang, G; Zeng, B; Zeng, X; Zhang, D | 1 |
| Byun, JK; Dang, DK; Jeong, JH; Jin, D; Kim, HC; Ko, SK; Nah, SY; Nguyen, YND; Park, JH; Sharma, N; Shin, EJ; Tran, HP; Tran, NKC; Xiaoyan, Z | 1 |
10 other study(ies) available for methamphetamine and ginsenosides
| Article | Year |
|---|---|
Inhibition by ginsenosides Rb1 and Rg1 of methamphetamine-induced hyperactivity, conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Central Nervous System Agents; Conditioning, Psychological; Ginsenosides; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred ICR; Receptors, Dopamine; Saponins | 1998 |
Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice.
Topics: Animals; Anxiety; Escape Reaction; Ginsenosides; Male; Maze Learning; Methamphetamine; Mice; Neuroprotective Agents; Plant Components, Aerial; Plant Extracts; Saponins | 2003 |
Ginsenosides attenuate methamphetamine-induced behavioral side effects in mice via activation of adenosine A2A receptors: possible involvements of the striatal reduction in AP-1 DNA binding activity and proenkephalin gene expression.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Behavior, Animal; Blotting, Northern; Cell Count; Central Nervous System Stimulants; Conditioning, Operant; Corpus Striatum; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electrophoretic Mobility Shift Assay; Enkephalins; Gene Expression; Ginsenosides; Immunohistochemistry; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Oncogene Proteins v-fos; Protein Precursors; Receptor, Adenosine A2A; RNA, Messenger; Stereotyped Behavior; Teprotide; Time Factors; Transcription Factor AP-1 | 2005 |
Pharmacological action of Panax ginseng on the behavioral toxicities induced by psychotropic agents.
Topics: Animals; Behavior; Cocaine; Conditioning, Psychological; Ginsenosides; Humans; Methamphetamine; Morphine; Panax; Psychotropic Drugs | 2005 |
Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase Cδ gene.
Topics: Animals; Dopaminergic Neurons; Ginsenosides; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Mitochondria; Nerve Degeneration; Oxidative Stress; Protein Kinase C-delta; Protein Kinase Inhibitors | 2014 |
Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines.
Topics: Antioxidants; Apoptosis Regulatory Proteins; Cell Line, Tumor; Central Nervous System Stimulants; Cytochromes c; Cytosol; Dopaminergic Neurons; Ginsenosides; Humans; Membrane Potential, Mitochondrial; Methamphetamine; Mitochondria; Neuroprotective Agents; Protein Kinase C-delta; Tyrosine 3-Monooxygenase | 2015 |
Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Dopamine; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; gamma-Aminobutyric Acid; Ginsenosides; Male; Methamphetamine; Mice; Mice, Inbred ICR; Neurons; Nucleus Accumbens; Receptors, Opioid, mu | 2016 |
Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
Topics: Animals; Dopamine; Dopaminergic Neurons; Dynorphins; Ginsenosides; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurokinin-1 Receptor Antagonists; Piperidines; Reactive Oxygen Species; Receptors, Neurokinin-1; Receptors, Opioid, kappa; Substance P; Up-Regulation | 2018 |
Protective Effects of Ginsenoside Rb1 against Blood-Brain Barrier Damage Induced by Human Immunodeficiency Virus-1 Tat Protein and Methamphetamine in Sprague-Dawley Rats.
Topics: AIDS-Associated Nephropathy; Animals; Blood-Brain Barrier; Ginsenosides; Glutathione; Male; Methamphetamine; Oxidative Stress; Permeability; Phytotherapy; Rats, Sprague-Dawley; Superoxide Dismutase; tat Gene Products, Human Immunodeficiency Virus | 2018 |
Ginsenoside Re blocks Bay k-8644-induced neurotoxicity via attenuating mitochondrial dysfunction and PKCδ activation in the hippocampus of mice: Involvement of antioxidant potential.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Antioxidants; Bays; Ginsenosides; Hippocampus; Methamphetamine; Mice; Mice, Knockout; Mitochondria; Seizures | 2023 |